Non-PVC IV bags find wide application in delivering fluids, medications, blood and blood products to patients intravenously. These bags provide a safer and biodegradable alternative to conventional PVC IV bags which release toxicants during manufacturing and disposal. The global Non-PVC IV Bags Market is estimated to be valued at US$ 700 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The increasing demand for safer and biodegradable IV bags is estimated to drive the growth of the Non-PVC IV Bags Market over the forecast period. Non-PVC IV bags do not release toxic phthalate plasticizers and are non-DEHP during manufacturing and disposal. They are also biodegradable thus provide environmental benefits over PVC bags.
Further, growing prevalence of chronic diseases and rising number of surgeries are other factors augmenting the demand for IV solutions and medications. According to the Centers for Disease Control and Prevention (CDC), in 2019, around 6 in 10 adults in the United States had at least one chronic disease and 4 in 10 adults had two or more chronic diseases. This increasing disease burden is expected to propel the demand for IV procedures, thereby driving the Non-PVC IV Bags Market growth over the forecast period.

SWOT Analysis
Strength: Non-PVC IV bags are free from phthalate ester plasticizers which are known carcinogens. They have high flexibility and durability which enhances patient comfort and ensures no issues during fluid administration. Non-PVC IV bags offer better stability, biocompatibility and do not affect drug potency.

Weakness: Non-PVC IV bags have higher production costs compared to conventional PVC bags which increases the cost of therapy. There are also limitations in raw material supply which affects large scale production of novel materials.

Opportunity: Increasing healthcare expenditure and growing patient awareness about health hazards of PVC boosts the demand for safer non-PVC alternatives. Rising prevalence of chronic diseases warranting prolonged IV therapies further drives the market growth. Technological advancements allowing customized development of tailor-made non-toxic materials present new opportunities.

Threats: Stringent regulatory norms governing medical devices increase the entry barriers. Established market dominance of conventional PVC products also poses threats from substitution. Unpredictable raw material prices affect supply stability in some regions.

Key Takeaways

The Global Non-PVC IV Bags Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The market is forecast to grow at a CAGR of 4.2% during this period.

Regional analysis: North America currently dominates the global non-PVC IV bags market owing to the growing incidences of chronic diseases and large healthcare expenditure in the region. The Asia Pacific region shows greatest potential for market growth in the coming years due to rising healthcare infrastructure, increasing medical tourism and growing medical needs of huge patient population in the region.

Key players: Key players operating in the non-PVC IV bags market are Baxter, Sippex, B.Braun, ICU Medical, Wipak Group, Technoflex, and Fresenius Kabi. These players focus on new product launches, partnerships and mergers to consolidate their market positions.

For more details on the report, Read- https://www.ukwebwire.com/non-pvc-iv-bags-market-trends-size-and-share-analysis/